Home
University & Research Institutions

Sector: University & Research Institutions

Historic CRISPR drug approval heralds new era in Cas9 IP wars

Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.

CRISPR-Cas9 drugmakers like Vertex should come to the table early, says ToolGen’s IP chief

Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals

Patent transactions in Q2 2023

The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023

Latest content

Everything you need to know about the covid-19 IP waiver negotiations

With text-based discussions of a TRIPS suspension about to get underway, IAM highlights the key issues to be aware of.

17 June 2021

The IP dangers in life sciences collaborations and how to avoid them

Partnership agreements are a growing part of the biopharma R&D process, so anticipating potential pitfalls in such arrangements is vital

14 June 2021

China bill moving through US Senate would create list of ‘IP violators’

The Strategic Competition Act of 2021 could also see increased use of sanctions to combat IP theft

28 April 2021

TRIPS covid vaccine IP waiver proposal fails to address crucial questions

President Biden and other leaders are coming under pressure to agree a suspension of IP rights, but a key point has been missed

20 April 2021

How India can chart a course to IP leadership

Top voices from industry and private practice reckon with the strengths and weaknesses of country’s IP environment

15 April 2021

Brazil suspends drug patent extensions and reschedules key Supreme Court hearing for tomorrow

Long-running constitutional challenge putting 40% of patents at-risk set to be resolved, but further delays are possible

13 April 2021

Multibillion-dollar BridgeBio deal is a boost for patent-centric pharma business models

Hub-and-spokes life sciences companies are providing new opportunities for IP monetisation

08 April 2021

How the EPO’s latest CRISPR revocation affects the Cas9 landscape

Sigma-Aldrich’s patent loss could be a sign of things to come for several ongoing opposition proceedings

01 April 2021

Japanese display lab looking toward China for next patent payday

Semiconductor Energy Lab settles US case against BOE and promptly targets China Star Optoelectronics, another major panel maker

29 March 2021

Top US patent filers: positions 1 to 100

Featured in Special Report 2021 Q1: On the shoulders of giants

25 March 2021

Unlock unlimited access to all IAM content